Conversely, BAs can suppress the expression of ER stress-related proteins, improve insulin resistance, and reduce blood glucose levels by modulating the JNK signaling pathway [31, 66]
Thats where Tirzepatide and Semaglutide come in
Research Linking GLP-1 Medications to NAION Multiple large-scale studies published in 2024-2025 documented alarming associations between semaglutide and dramatically elevated NAION rates
The primary goal of this article is to emphasize the extensive benefits of using GLP-1RAs in treating a broad spectrum of diseases, such as obesity, cardiovascular diseases, non-alcoholic fatty liver disease (NAFLD), neurodegenerative diseases, musculoskeletal inflammation, and various forms of cancer
Novo Nordisk sells semaglutide as Wegovy for weight management and as Ozempic for type 2 diabetes